Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B
The independent risk factors of HCC occurrence are age ≥ 50 years, male, platelet count≤ 150 × 10<sup>9</sup>/L, albumin level ≤ 44 g/L, with cirrhosis at HBsAg seroclearance and AVT-induced HBsAg seroclearance. Our six-factor model enables risk stratification among patients achieving HBsAg seroclearance and may assist in informing surveillance strategies in clinical practice.
Authors
- Yuqi Hong
- Yujing Wang (ORCID: https://orcid.org/0000-0003-2197-8983)
- Shuaibing Ying
- Z. Zhang (ORCID: https://orcid.org/0009-0008-7117-2121)
- Yu Guo (ORCID: https://orcid.org/0000-0002-7560-0225)
- Jinyao Dai
- Qiudan Zhang (ORCID: https://orcid.org/0000-0001-6067-8188)
- Yunqing Qiu (ORCID: https://orcid.org/0000-0003-0135-3935)
- S.J. Dong
- Haoyang Hu (ORCID: https://orcid.org/0009-0001-8604-7277)
- Yichun Zhang (ORCID: https://orcid.org/0009-0006-8733-5795)
- Haomin Yan
- Yina Yu
- Yan Lou
- Yi Liu
Institutions
- Westlake University (CN)
- National Clinical Research (US)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1111/apt.70637
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 23.38